Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II.
Siva S, Chesson B, Bressel M, Pryor D, Higgs B, Reynolds HM, Hardcastle N, Montgomery R, Vanneste B, Khoo V, Ruben J, Lau E, Hofman MS, De Abreu Lourenco R, Sridharan S, Brook NR, Martin J, Lawrentschuk N, Kron T, Foroudi F. Siva S, et al. Among authors: khoo v. BMC Cancer. 2018 Oct 23;18(1):1030. doi: 10.1186/s12885-018-4916-2. BMC Cancer. 2018. PMID: 30352550 Free PMC article. Clinical Trial.
The use of hydrogel spacer in men undergoing high-dose prostate cancer radiotherapy: results of a prospective phase 2 clinical trial.
Chao M, Lim Joon D, Khoo V, Lawrentschuk N, Ho H, Spencer S, Chan Y, Tan A, Pham T, Sengupta S, McMillan K, Liu M, Koufogiannis G, Cham CW, Foroudi F, Bolton D. Chao M, et al. Among authors: khoo v. World J Urol. 2019 Jun;37(6):1111-1116. doi: 10.1007/s00345-018-2502-5. Epub 2018 Sep 24. World J Urol. 2019. PMID: 30251049 Clinical Trial.
Fiducial markers: can the urologist do better?
Duncan C, Joon DL, Lawrentschuk N, Jenkins T, Schneider M, Khoo V, Chao M, Lawlor M, O'Meara R, Berry C, Viotto A, Brown K, Wada M, Foroudi F, Sengupta S. Duncan C, et al. Among authors: khoo v. World J Urol. 2019 Jul;37(7):1281-1287. doi: 10.1007/s00345-018-2515-0. Epub 2018 Oct 4. World J Urol. 2019. PMID: 30288597
High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomes.
Chao M, Bolton D, Lim Joon D, Chan Y, Lawrentschuk N, Ho H, Spencer S, Wasiak J, Guerrieri M, Ow D, Troy A, Pham T, Sengupta S, Tan A, McMillan K, Koufogiannis G, Foroudi F, Ng M, Khoo V. Chao M, et al. Among authors: khoo v. J Med Imaging Radiat Oncol. 2019 Jun;63(3):415-421. doi: 10.1111/1754-9485.12882. Epub 2019 Mar 25. J Med Imaging Radiat Oncol. 2019. PMID: 30908894
Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
Ong WL, Koh TL, Lim Joon D, Chao M, Farrugia B, Lau E, Khoo V, Lawrentschuk N, Bolton D, Foroudi F. Ong WL, et al. Among authors: khoo v. BJU Int. 2019 Nov;124 Suppl 1:19-30. doi: 10.1111/bju.14886. Epub 2019 Sep 11. BJU Int. 2019. PMID: 31507035 Review.
Proximal seminal vesicle displacement and margins for prostate cancer radiotherapy.
Lim Joon D, Chao M, Piccolo A, Schneider M, Anderson N, Handley M, Benci M, Ong WL, Daly K, Morrell R, Wan K, Lawrentschuk N, Foroudi F, Jenkins T, Angus D, Wada M, Sengupta S, Khoo V. Lim Joon D, et al. Among authors: khoo v. J Med Radiat Sci. 2021 Sep;68(3):289-297. doi: 10.1002/jmrs.457. Epub 2021 Jan 12. J Med Radiat Sci. 2021. PMID: 33432719 Free PMC article.
315 results